Trials / Completed
CompletedNCT03698513
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
A Randomized, Cross-over Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986177 (an Oral Antithrombotic) With Single and Dual Antiplatelet Therapy (Aspirin and Clopidogrel) in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 113 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the safety and interaction of BMS-986177 in healthy volunteers, when administered with Aspirin and/or Clopidogrel
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986177 | BMS-986177 capsule |
| OTHER | Placebo (for BMS-986177) | BMS-986177 placebo match capsule |
| DRUG | Clopidogrel | Clopidogrel tablet |
| DRUG | Aspirin | Aspirin tablet |
Timeline
- Start date
- 2018-10-04
- Primary completion
- 2019-02-19
- Completion
- 2019-02-19
- First posted
- 2018-10-09
- Last updated
- 2021-09-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03698513. Inclusion in this directory is not an endorsement.